Clinical Trials Directory

Trials / Completed

CompletedNCT03199716

Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
10 Years – 15 Years
Healthy volunteers
Not accepted

Summary

The study aim is to determine if parent mentors can improve adherence to the intensive multiple daily injection regimen (MDI) or the insulin pump therapy, through monitoring the frequency of blood glucose measurements. Researchers are also trying to determine if the parent mentors can improve glycemic control, which is measured through HbA1c. The study hypothesis is that trained parent mentors can help families with children who have poorly controlled T1DM improve adherence to their diabetes regimen and improve their metabolic control.

Detailed description

The study aim is to determine if parent mentors can improve adherence to the intensive multiple daily injection regimen (MDI) or the insulin pump therapy, through monitoring the frequency of blood glucose measurements. Researchers are also trying to determine if the parent mentors can improve glycemic control, which is measured through HbA1c. Diabetic knowledge, responsibility for diabetes care, degree of diabetes related family conflicts, and major complications of diabetes will also be collected during the patient's routine clinic visit. The study hypothesis is that trained parent mentors can help families with children who have poorly controlled T1DM improve adherence to their diabetes regimen and improve their metabolic control.

Conditions

Interventions

TypeNameDescription
OTHERParent mentorsParent mentors are to meet up with their assigned intervention group 4 times in 1 year and call the families monthly to document any diabetic complications

Timeline

Start date
2014-09-01
Primary completion
2017-03-23
Completion
2017-03-23
First posted
2017-06-27
Last updated
2019-06-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03199716. Inclusion in this directory is not an endorsement.